厄贝沙坦氢氯噻嗪与硝苯地平联合治疗老年高血压合并糖尿病患者的临床疗效和安全性
DOI:
CSTR:
作者:
作者单位:

漯河市召陵区人民医院西内科

作者简介:

通讯作者:

中图分类号:

基金项目:


Clinical efficacy and safety of irbesartan hydrochlorothiazide combined with nifedipine in the treatment of elderly patients with hypertension combined with diabetes mellitus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨老年高血压合并糖尿病患者应用硝苯地平与厄贝沙坦氢氯噻嗪协同治疗的疗效及对血清炎症因子的影响。方法:2022年5月到2024年4月,选择所在医院诊治的100例老年高血压合并糖尿病患者,以随机数字表法分成观察组与对照组,各50例。两组均予以常规对症治疗,同时对照组予以硝苯地平治疗,观察组予以硝苯地平+厄贝沙坦氢氯噻嗪治疗。对比临床疗效与安全性,对比治疗前后血糖【餐后2h血糖(2hPG)、空腹血糖(FPG)】、血压【收缩压(SBP)、舒张压(DBP)】、血清炎症因子【肿瘤坏死因子-α(TNF-α)、白介素-8(IL-8)、C反应蛋白(CRP)】。结果:观察组治疗总有效率(96.00%)比对照组(82.00%)高(P<0.05);治疗3周,两组SBP、DBP、2hPG、FPG、TNF-α、IL-8、CRP与治疗前相比均下降,观察组更低(P<0.05);两组用药后不良反应发生率对比,差异无统计学意义(P>005)。结论:老年高血压合并糖尿病患者应用硝苯地平与厄贝沙坦氢氯噻嗪协同治疗,疗效确切,可有效调节机体血糖与血压水平,还可减轻疾病对血清炎症因子的影响,用药后不会引起严重不良反应,安全性较高。

    Abstract:

    Objective: To investigate the efficacy of applying nifedipine and irbesartan hydrochlorothiazide synergistic treatment in elderly patients with hypertension combined with diabetes mellitus and the effect on serum inflammatory factors. Methods: From May 2022 to April 2024, 100 cases of elderly patients with hypertension combined with diabetes mellitus diagnosed and treated in the hospital where we were located were selected, and divided into observation group and control group by randomized numerical table method, 50 cases each. Both groups were treated with conventional symptomatic treatment, while the control group was treated with nifedipine and the observation group was treated with nifedipine + irbesartan hydrochlorothiazide. Comparison of clinical efficacy and safety, before and after the treatment of blood glucose [2h postprandial glucose (2hPG), fasting glucose (FPG)], blood pressure [systolic blood pressure (SBP), diastolic blood pressure (DBP)], serum inflammatory factors [tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), C-reactive protein (CRP)]. Results: The total effective rate of treatment in the observation group (96.00%) was higher than that in the control group (82.00%) (P < 0.05); after 3 weeks of treatment, SBP, DBP, 2hPG, FPG, TNF-α, IL-8, and CRP decreased in the two groups compared with the pre-treatment period, and were lower in the observation group (P < 0.05); the differences in the incidence of adverse reactions between the two groups after the use of medication were not statistically significant when comparing the rates of the two groups (P> 005). Conclusion: The synergistic treatment of nifedipine and irbesartan hydrochlorothiazide in elderly patients with hypertension combined with diabetes mellitus has a precise therapeutic efficacy, which can effectively regulate the body"s blood glucose and blood pressure levels, and also reduce the impact of the disease on the serum inflammatory factor, which will not cause serious adverse reactions after the use of the drug, and has a high degree of safety.

    参考文献
    相似文献
    引证文献
引用本文

宛瑞丽.厄贝沙坦氢氯噻嗪与硝苯地平联合治疗老年高血压合并糖尿病患者的临床疗效和安全性[J].四川生理科学杂志,2026,48(8):

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-02-27
  • 最后修改日期:2026-06-09
  • 录用日期:2026-06-29
  • 在线发布日期: 2026-08-15
  • 出版日期:
文章二维码